Point72 Hong Kong Ltd bought a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm bought 13,935 shares of the financial services provider’s stock, valued at approximately $1,141,000.
Several other hedge funds have also recently made changes to their positions in MET. Norges Bank bought a new position in shares of MetLife in the 4th quarter worth about $730,716,000. Price T Rowe Associates Inc. MD increased its position in MetLife by 33.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider’s stock valued at $2,019,427,000 after buying an additional 6,213,923 shares in the last quarter. Bank of New York Mellon Corp increased its position in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after buying an additional 4,606,748 shares in the last quarter. Clearbridge Investments LLC increased its position in MetLife by 43.7% in the 4th quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider’s stock valued at $463,701,000 after buying an additional 1,723,461 shares in the last quarter. Finally, Swedbank AB increased its position in MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after buying an additional 1,496,645 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently commented on MET. Barclays decreased their target price on MetLife from $95.00 to $88.00 and set an “overweight” rating for the company in a research report on Friday, April 11th. Piper Sandler increased their price objective on MetLife from $92.00 to $94.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research note on Monday, May 5th. Cowen reissued a “buy” rating on shares of MetLife in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. lowered their price objective on MetLife from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, April 2nd. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, MetLife has an average rating of “Moderate Buy” and a consensus price target of $92.69.
MetLife Stock Performance
Shares of MET opened at $80.42 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a 50 day moving average of $76.99 and a 200 day moving average of $81.15. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a market capitalization of $53.99 billion, a price-to-earnings ratio of 13.47, a PEG ratio of 0.65 and a beta of 0.85.
MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.00 by ($0.04). MetLife had a return on equity of 20.42% and a net margin of 6.19%. The firm had revenue of $18.57 billion during the quarter, compared to analysts’ expectations of $18.06 billion. During the same period in the prior year, the business earned $1.83 earnings per share. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 6th will be given a $0.5675 dividend. This is an increase from MetLife’s previous quarterly dividend of $0.55. This represents a $2.27 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date of this dividend is Tuesday, May 6th. MetLife’s dividend payout ratio (DPR) is currently 36.91%.
MetLife declared that its Board of Directors has authorized a stock buyback plan on Wednesday, April 30th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Walmart Stock Alert: Big Price Move Expected Soon
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Consumer Staples Stocks, Explained
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.